Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role - ScienceDirect
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Kappa opioid receptor (KOR) modulation of dopamine in the cortex and... | Download Scientific Diagram
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Enhancing Remyelination through a Novel Opioid-Receptor Pathway | Journal of Neuroscience
Seeking (and Finding) Biased Ligands of the Kappa Opioid Receptor. | Semantic Scholar
Structure of the human κ-opioid receptor in complex with JDTic | Nature
RETRACTED ARTICLE: Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway | Cell Communication and Signaling | Full Text
Peptide Analgesics – Opioid Peptides
Antagonists of the kappa opioid receptor - ScienceDirect
Opioids in cancer: The κ‑opioid receptor (Review)
Kappa Opiate Receptor - an overview | ScienceDirect Topics
The Role of Opioids and Their Receptors in Urological Malignancy: A Review | Journal of Urology
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role | Semantic Scholar
Kinase cascades and ligand-directed signaling at the kappa opioid receptor | Psychopharmacology
κ-opioid receptor - Wikipedia
Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress | eLife
Biased Opioid Receptor Ligands: Gain without Pain: Trends in Endocrinology & Metabolism
Nephrology Journal Club on X: "Difelikefalin (CR845) (KORSUVA) is a peripherally restricted, selective kappa opioid receptor agonist that exerts antipruritic effects by means of activation of kappa opioid receptors on peripheral neurons
Kappa opioids inhibit the GABA/glycine terminals of rostral ventromedial medulla projections in the superficial dorsal horn of the spinal cord - Otsu - 2022 - The Journal of Physiology - Wiley Online Library
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
